secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lineage Cell Therapeutics, Inc. (LCTX)
CIK:        0000876343
Form:       8-K
Filed at:   2024-02-15T23:59:59+00:00
Accession:  0001493152-24-006901
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Annual meeting set for June 11, 2024; shareholder proposal deadlines announced
------------------------------------------------------------------------------

- 2024 annual meeting of shareholders scheduled for June 11, 2024.
- Shareholder business or director nominations due by March 15, 2024.
- Shareholder proposals for proxy statement inclusion due by March 29, 2024.
- Notices directed to Corporate Secretary at Carlsbad, CA address.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/876343/000149315224006901/0001493152-24-006901-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/876343/000149315224006901/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-006901

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer